Zobrazeno 1 - 5
of 5
pro vyhledávání: '"M. V. Borodavkina"'
Publikováno v:
Human Physiology. 27:42-47
A group of parturient women was divided on the basis of a special psychological poll into subgroups with a high (changed mental state, CMS) and low (unchanged mental state, UMS) number of signs of changes in the mental state during and after delivery
Autor:
T. A. Voronina, Yu. L. Dugina, I. A. Kheyfets, M. V. Borodavkina, O. I. Epshtein, Svetlana Alexandrovna Sergeeva, G. M. Molodavkin
Publikováno v:
Bulletin of Experimental Biology and Medicine. 148:527-529
Experiments on rats demonstrated antiaggressive activity of ultralow doses of antibodies to S-100 protein in tests of motivated and unmotivated aggression. The effect of ultralow doses of antibodies to S-100 protein in single and course treatment was
Autor:
Svetlana Alexandrovna Sergeeva, G. M. Molodavkin, M. V. Borodavkina, I. A. Kheyfets, Yu. L. Dugina, T. A. Voronina
Publikováno v:
Bulletin of Experimental Biology and Medicine. 148:524-526
The antiamnestic effects of tenoten (pediatric formulation) was demonstrated on the model of scopolamine-induced amnesia of passive avoidance reflex and the nootropic effect of this preparation was demonstrated on the model of incomplete conditioning
Autor:
M. V. Borodavkina, N. A. Zhukova, T. V. Ogorodnikova, M. P. Dolgikh, Yu. L. Dugina, S. A. Sergeeva, T. G. Tolstikova, I. V. Sorokina
Publikováno v:
Bulletin of Experimental Biology and Medicine. 148:540-542
Screening of three potential antiulcer preparations containing ultralow doses of antibodies to endogenous regulators of ulcer formation (gastrin, histamine, and H2 histamine receptors) on the model of acetic acid-induced gastric ulcer in rats reveale
Autor:
N. A. Zorin, M. V. Borodavkina, A. V. Nosyrev, M. V. Kachanova, S. Yu. Barkhatova, I. A. Kheifets, M. V. Barkhatov, L. V. Sabanov
Publikováno v:
Bulletin of Experimental Biology and Medicine. 148:337-339
Tension-type headaches are the most common type of headaches in children. No effective treatment for this disease is developed yet. After treatment with tenoten, the number of days with headache in 9-17-years-old children decreased by 40.9%, the mean